{"id":4498,"date":"2010-11-10T16:12:24","date_gmt":"2010-11-10T21:12:24","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?p=4498"},"modified":"2011-07-19T17:45:12","modified_gmt":"2011-07-19T21:45:12","slug":"alzheimers-disease-and-cholesterol-a-tricky-relationship","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/11\/10\/alzheimers-disease-and-cholesterol-a-tricky-relationship\/","title":{"rendered":"Alzheimer&#8217;s Disease and Cholesterol: A Tricky Relationship"},"content":{"rendered":"<p><em>A <a href=\"http:\/\/www.neurology.org\/content\/early\/2010\/11\/10\/WNL.0b013e3181feb2bf.abstract?sid=a9b0dfa6-0817-4c87-bf1c-09b460ef10a4\">recent study in <span style=\"font-style: normal;\">Neurology<\/span><\/a> found that cholesterol levels in mid-life were not linked to the development of Alzheimer&#8217;s disease in older age. In fact, the study by Michelle Mielke and colleagues found that large drops\u00a0in cholesterol levels in old age were a harbinger of Alzheimer&#8217;s. CardioExchange asked Cynthia Carlsson, Assistant Professor and Alzheimer&#8217;s researcher at the University of Wisconsin School of Medicine and Public Health, to provide an expert perspective on this counterintuitive finding.<\/em><\/p>\n<p>There has been a lot of controversy as to what role cholesterol plays in the development of dementia. To date, studies suggest that elevated midlife cholesterol increases the risk of Alzheimer&#8217;s disease. This idea is also supported by animal studies that show increased cholesterol triggers the development of the hallmark amyloid plaques in the brains of animals. In addition to Dr. Mielke&#8217;s study, other investigators have shown in longitudinal analyses that blood cholesterol levels tend to be higher in midlife and then drop later in life prior to the onset of dementia.<\/p>\n<p>Some believe this reflects the subclinical disease process leading to either dietary changes or other inflammatory changes that alter the blood cholesterol levels. Because serum cholesterol is a negative, acute-phase reactant, with an increased inflammatory state (such as during acute or chronic illness) serum cholesterol levels decline. Alzheimer&#8217;s disease is associated with inflammatory changes; thus, it could theoretically trigger a decline in serum cholesterol.<\/p>\n<p>Therefore, I am not too surprised that Dr. Mielke found that those individuals with the greatest cholesterol decline had the highest risk of Alzheimer&#8217;s disease: These results most likely reflect that the person is progressing to a disease state, rather than the low-cholesterol levels triggering the dementia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A recent study in Neurology found that cholesterol levels in mid-life were not linked to the development of Alzheimer&#8217;s disease in older age. In fact, the study by Michelle Mielke and colleagues found that large drops\u00a0in cholesterol levels in old age were a harbinger of Alzheimer&#8217;s. CardioExchange asked Cynthia Carlsson, Assistant Professor and Alzheimer&#8217;s researcher [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,7,16],"tags":[540,210,271],"class_list":["post-4498","post","type-post","status-publish","format-standard","hentry","category-general","category-prevention","category-vascular","tag-alzheimer-disease","tag-cholesterol","tag-risk-factors"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/4498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=4498"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/4498\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=4498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=4498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=4498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}